Meeder Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$34.6K Buy
322
+60
+23% +$6.45K ﹤0.01% 428
2025
Q1
$26.4K Sell
262
-121
-32% -$12.2K ﹤0.01% 491
2024
Q4
$34.2K Sell
383
-33
-8% -$2.95K ﹤0.01% 431
2024
Q3
$34.9K Buy
416
+40
+11% +$3.35K ﹤0.01% 418
2024
Q2
$29K Sell
376
-3,726
-91% -$287K ﹤0.01% 442
2024
Q1
$281K Buy
4,102
+299
+8% +$20.5K 0.02% 270
2023
Q4
$220K Sell
3,803
-158
-4% -$9.13K 0.02% 288
2023
Q3
$209K Buy
+3,961
New +$209K 0.02% 281
2022
Q4
Sell
-25,222
Closed -$977K 952
2022
Q3
$977K Buy
25,222
+3,653
+17% +$142K 0.06% 253
2022
Q2
$804K Buy
21,569
+1,781
+9% +$66.4K 0.05% 303
2022
Q1
$876K Buy
+19,788
New +$876K 0.04% 283
2021
Q4
Sell
-14,115
Closed -$612K 1322
2021
Q3
$612K Buy
14,115
+1,311
+10% +$56.8K 0.03% 366
2021
Q2
$547K Buy
12,804
+1,631
+15% +$69.7K 0.03% 461
2021
Q1
$432K Buy
11,173
+4,175
+60% +$161K 0.02% 532
2020
Q4
$252K Buy
6,998
+174
+3% +$6.27K 0.06% 272
2020
Q3
$261K Buy
6,824
+1,366
+25% +$52.2K 0.02% 540
2020
Q2
$192K Buy
5,458
+1,974
+57% +$69.4K 0.01% 612
2020
Q1
$114K Sell
3,484
-6
-0.2% -$196 0.01% 679
2019
Q4
$158K Buy
3,490
+874
+33% +$39.6K 0.01% 664
2019
Q3
$106K Buy
2,616
+485
+23% +$19.7K 0.01% 776
2019
Q2
$92K Buy
2,131
+2,052
+2,597% +$88.6K 0.01% 781
2019
Q1
$3K Buy
+79
New +$3K ﹤0.01% 1481
2018
Q3
Sell
-1,517
Closed -$49.6K 1547
2018
Q2
$49.6K Buy
+1,517
New +$49.6K ﹤0.01% 757
2018
Q1
Sell
-11,836
Closed -$293K 1574
2017
Q4
$293K Buy
+11,836
New +$293K 0.02% 416
2017
Q2
Sell
-13,681
Closed -$340K 1665
2017
Q1
$340K Buy
13,681
+12,535
+1,094% +$312K 0.03% 440
2016
Q4
$25K Sell
1,146
-75,817
-99% -$1.65M ﹤0.01% 623
2016
Q3
$1.83M Sell
76,963
-12,348
-14% -$294K 0.16% 147
2016
Q2
$2.09M Buy
89,311
+58,133
+186% +$1.36M 0.2% 112
2016
Q1
$586K Buy
31,178
+2,621
+9% +$49.3K 0.06% 350
2015
Q4
$526K Buy
28,557
+8,070
+39% +$149K 0.05% 312
2015
Q3
$335K Buy
+20,487
New +$335K 0.03% 448